C18(2R-OH) Galactosyl(β) Ceramide
| Catalog Number | BL-M001114 |
| CAS Number | 35823-62-2 |
| Description | C18(2R-OH) Galactosyl(β) Ceramide is a biosynthetic ceramide derivative with promising implications for cellular signaling and membrane behavior exploration. Its intricate involvement in glycosphingolipid synthesis offers avenues for therapeutic interventions in realms such as neurodegenerative ailments and cancer. |
 | |
| IUPAC Name | (2R)-2-hydroxy-N-[(E,2S,3R)-3-hydroxy-1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]octadecanamide |
| Synonyms | D-galactosyl-beta1-1'-N-[2''(R)-hydroxystearoyl]-D-erythro-sphingosine |
| Molecular Weight | 744.09 |
| Molecular Formula | C42H81NO9 |
| Purity | >99% |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 67.79%, H 10.97%, N 1.88%, O 19.35% |
| Canonical SMILES | CCCCCCCCCCCCCCCCC(C(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O)O |
| InChI | InChI=1S/C42H81NO9/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-36(46)41(50)43-34(33-51-42-40(49)39(48)38(47)37(32-44)52-42)35(45)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h28,30,34-40,42,44-49H,3-27,29,31-33H2,1-2H3,(H,43,50)/b30-28+/t34-,35+,36+,37+,38-,39?,40?,42+/m0/s1 |
| InChI Key | ONDPKGSAWAOCRS-HVZKFFKMSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
